Briefs: Sun Pharmaceutical Industries and Biocon Biologics
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
These re-agent and diagnostic test kits come with 99.7% accuracy
Sun Pharmaceutical Industries has reported total income of Rs. 12,630.9 crores during the period ended December 31, 2023
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The company has reported total income of Rs. 11303.95 crores during the period ended March 31, 2023
The order marks a significant milestone for MMP Industries that will contribute to the company's revenue in the coming financial year
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Subscribe To Our Newsletter & Stay Updated